The deal, expected to close in the second half of 2026, comes as Kenvue's Tylenol political fight is heating up.

The recent publicity could allow the company to get a good deal on Kenvue, which makes Tylenol, Band-Aids, and other ...

Kimberly-Clark is acquiring Tylenol maker Kenvue in a $48.7 billion cash-and-stock deal, creating a major consumer health goods company if shareholders approve.

IP, M&A, life sciences and competition partners advised on deal that brings together brands such as ‘Huggies’ and ‘Kleenex’ ...

Kenvue’s stock, which had hit a record low in recent weeks, was headed for its best day ever, while Kimberly-Clark’s stock ...

Former Vice President Dick Cheney has died at age 84. And, today, voters in New York, Virginia and New Jersey choose new ...

Kimberly-Clark plans to acquire Kenvue in a $48.7 billion deal, aiming to boost long-term growth and synergies. Learn more ...

Kimberly-Clark, the maker of Huggies, said Monday it will acquire Kenvue, Tylenol’s parent, in a cash-and-stock transaction valued at nearly $50 billion. The companies said the combined portfolio will ...

Aid, Huggies, and Kleenex are now under one roof. In a major business deal worth $48.7 billion, Kimberly-Clark, the company behind Huggies diapers and Kleenex tissues, is buying Kenvue, […] The post ...

One of the biggest mergers of the year, worth $49 billion, comes just weeks after the Trump administration linked the common ...

The consumer health and wellness giants are both Dividend Kings, with more than 50 years of consecutive annual payout ...